SRx Health Solutions (SRXH)
XASE:SRXH
Want to see SRXH full AI Analyst Report?
SRXH Stock Chart & Stats
$0.24
--
Market closed
$0.24
--
Day’s Range― - ―
52-Week Range$0.08 - $0.78
Previous CloseN/A
VolumeN/A
Average Volume (3M)695.52K
Market Cap
$76.14M
Enterprise Value$6.40M
Total Cash (Recent Filing)$26.07M
Total Debt (Recent Filing)$22.62M
Price to Earnings (P/E)―
Beta0.19
Next Earnings
May 20, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.76
Shares Outstanding590,254,760
10 Day Avg. Volume504,141
30 Day Avg. Volume695,518
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)16.44
Price to Sales (P/S)1.02
P/FCF Ratio-0.82
Enterprise Value/Market Cap0.08
Enterprise Value/Revenue-0.38
Enterprise Value/Gross Profit-1.34
Enterprise Value/Ebitda-0.17
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1.32
Revenue Forecast (FY)$95.00M
Bulls Say, Bears Say
Bulls Say
Specialty Pharmacy Business ModelSRx operates a specialty pharmacy and patient-support services business, a durable model tied to long-term specialty therapies and payer relationships. These services generate recurring dispensing and manufacturer-paid support fees, creating stickiness and predictable demand as specialty drug use grows.
Underlying Service-level MarginsDespite volatile results, reported positive gross and EBIT margins indicate core pharmacy and services have inherent pricing power and operational scalability. If operating expenses and financing pressures are managed, the business can convert underlying unit economics into sustainable profitability over the medium term.
Strategic Merger To Bolster Treasury CapabilityThe planned EMJ Crypto Technologies merger aims to create an institutional-grade, rules-based treasury operating system. Successfully integrating EMJX could improve treasury returns, reduce reliance on dilutive financings and add recurring, non-operational income streams that strengthen capital efficiency over time.
Bears Say
Very High LeverageExtremely elevated debt-to-equity and a history of negative equity materially constrain financial flexibility. High leverage amplifies refinancing and interest-rate risk, limits ability to invest in operations, and increases the probability of distress if operating results or treasury returns falter over the coming quarters.
Persistent Negative Cash FlowSustained operating and free cash flow deficits reflect structural cash burn and reliance on external financing. Ongoing negative cash generation raises refinancing and dilution risk, constrains investment in core growth initiatives and could force cost cutting or further capital raises if losses persist.
Large Treasury Redeployments To High-risk AssetsRedeploying meaningful treasury capital into AI/space SPVs and merging with a crypto-focused firm materially increases portfolio risk and strategic drift away from healthcare operations. This concentration and unfamiliar asset exposure raise volatility, governance and execution risk for the core business over the medium term.
SRx Health Solutions News
SRXH FAQ
What was SRx Health Solutions’s price range in the past 12 months?
SRx Health Solutions lowest stock price was $0.08 and its highest was $0.78 in the past 12 months.
What is SRx Health Solutions’s market cap?
SRx Health Solutions’s market cap is $76.14M.
When is SRx Health Solutions’s upcoming earnings report date?
SRx Health Solutions’s upcoming earnings report date is May 20, 2027 which is in 362 days.
How were SRx Health Solutions’s earnings last quarter?
SRx Health Solutions released its earnings results on May 14, 2026. The company reported -$0.021 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.021.
Is SRx Health Solutions overvalued?
According to Wall Street analysts SRx Health Solutions’s price is currently Overvalued.
Does SRx Health Solutions pay dividends?
SRx Health Solutions does not currently pay dividends.
What is SRx Health Solutions’s EPS estimate?
SRx Health Solutions’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does SRx Health Solutions have?
SRx Health Solutions has 590,254,760 shares outstanding.
What happened to SRx Health Solutions’s price movement after its last earnings report?
SRx Health Solutions reported an EPS of -$0.021 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -9.42%.
Which hedge fund is a major shareholder of SRx Health Solutions?
Currently, no hedge funds are holding shares in SRXH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
SRx Health Solutions Stock Smart Score
Company Description
SRx Health Solutions
SRx Health Solutions Inc. is an integrated Canadian healthcare services provider operating within the specialty healthcare industry. The company offers comprehensive, integrated, and customized specialty healthcare services across all ten Canadian provinces. SRx combines industry knowledge, technology, and a patient-centric focus to create strategies and solutions aimed at improving the wellness of Canadians.
Technical Analysis
Grifols SA
―
Scilex Holding Company
―
Organon
―
Citius Oncology
―
MIRA Pharmaceuticals, Inc.
―
Ownership Overview
0.28% Insiders
0.04% Mutual Funds
0.04% Other Institutional Investors
99.64% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---